ASPN, A NOVEL INHIBITOR OF TGFBETA AND A PUTATIVE BIOMARKER FOR AGGRESSIVE PROSTATE CANCER

$364,500FY2012Department of the ArmyDOD

The Johns Hopkins University

Investigators